SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

BUB Bubs Australia Limited

Consumer Defensive · Packaged Foods · website · 118 employees
$0.10
52wk 0.08 – 0.17
Overall
48.4
Value
86.2
Growth
51.5
Health
59.0
Quality
0.0
Momentum
28.3
Dividend
—
Price
About Bubs Australia Limited

Bubs Australia Limited, together with its subsidiaries, manufactures and sell infant and adult chilled and powdered goat dairy products in Australia, China, the United States, and internationally. The company provides goat and cow milk infant formulas, goat milk powder products for adults, and fresh dairy products. It also offers organic baby food, cereals, snacks, and chilled goat milk. In addition, the company holds IP and trademarks. It sells its products under the Bubs and Caprilac brands. The company exports its products. Bubs Australia Limited was founded in 2005 and is based in Dandenong, Australia.

Price analytics

Returns

1 day -1.0%
1 week -5.7%
1 month 6.5%
3 months 20.7%
6 months -5.7%
1 year -29.3%
3 years -40.0%

Risk

Volatility (1y ann.) 58.6%
Beta vs ASX 200 0.31
Sharpe (1y) -0.38
VaR 95% (1-day) -4.8%
Max drawdown (1y) -53.3%
Off 1-year high -40.0%

Technicals

RSI(14) 34
vs 50DMA 0.6%
vs 200DMA -6.2%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 86.2
Trailing P/E
—
Forward P/E
68
PEG ratio
—
EV / EBITDA
100
Price / Book
80
Price / Sales
100
Growth 51.5
Revenue growth (1y)
54
Revenue CAGR (3y)
100
EPS growth (1y)
0
EPS CAGR (3y)
—
Financial Health 59.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
81
Debt / Equity
88
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 28.3
6-month return vs ASX 200
13
Price vs 200-day average
29
Price vs 50-day average
53
Position in 52-week range
26

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$88.52M
P/E (trailing)
—
P/E (forward)
16.69
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
0.30
EV / EBITDA
-25.23
Price / Book
2.25
ROE
-11.3%
Operating margin
-10.2%
Net margin
-4.1%
Total cash
$9.41M
Total debt
$15.92M
Current ratio
2.18
Debt / Equity
0.41
Free cash flow
$-16.53M
Avg volume
1.74M
Latest annual results (FY ending 30 Jun 2026)
  • Revenue$111.86M
  • Gross profit$44.49M
  • Operating income-$5.61M
  • Net income-$4.62M
  • Diluted EPS-0.01
  • Free cash flow-$16.35M
  • Net debt$6.51M
Sector peers (Consumer Defensive)
TickerMkt cap P/EScore
WOW $46.85B 41.7 35.9
COL $30.95B 28.4 42.5
EDV $5.35B 99.3 24.2
A2M $4.86B 29.0 48.3
TWE $4.54B — 51.6
MTS $3.18B 11.6 48.9
BGA $1.92B 34.8 44.4
GNC $1.43B — 35.9